An estimated 27% of U.S. adults with diabetes are using glucagon-like peptide-1 receptor agonists (GLP-1 RAs) - a type of ...
A study on over 800k adults with type 2 diabetes found that semaglutide and other GLP-1 drugs did not increase or decrease ...
A new study found that students and staff involved with collegiate recovery programs had very different definitions and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results